The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-[(E)-naphthalene-2-sulfonylimino]-imidazolidine-1-carbodithioic acid 3-thioxo-5,6-dihydro-imidazo[2,1-c][1,2,4]thiadiazol-7-yl ester ID: ALA210620
PubChem CID: 44413038
Max Phase: Preclinical
Molecular Formula: C18H16N6O2S5
Molecular Weight: 508.70
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=S(=O)(NC1=NCCN1C(=S)SN1CCn2c1nsc2=S)c1ccc2ccccc2c1
Standard InChI: InChI=1S/C18H16N6O2S5/c25-31(26,14-6-5-12-3-1-2-4-13(12)11-14)21-15-19-7-8-22(15)18(28)30-24-10-9-23-16(24)20-29-17(23)27/h1-6,11H,7-10H2,(H,19,21)
Standard InChI Key: NOZMFXACNKQZDD-UHFFFAOYSA-N
Molfile:
RDKit 2D
31 35 0 0 0 0 0 0 0 0999 V2000
6.9477 -1.5511 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.7208 -1.8467 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
8.2426 -1.2078 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9900 -0.7290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7911 -0.5126 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.8336 0.3132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0605 0.6088 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5386 -0.0377 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.0684 -1.2465 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
5.7165 0.0086 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
5.3031 0.7226 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4795 0.7226 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.7165 1.4366 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
3.9881 1.3890 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2034 1.1363 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2034 0.3128 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.9881 0.0560 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2486 -0.7287 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.6604 -1.3132 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
4.2486 -1.8978 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.0755 -0.7287 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.0755 -1.8978 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2838 -1.6864 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7162 -3.2786 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2975 -2.6933 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9132 -3.0662 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7074 -2.2698 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9163 -2.0514 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3305 -2.6283 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5409 -3.4267 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3316 -3.6413 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8 10 1 0
10 11 1 0
11 12 1 0
11 13 2 0
12 14 1 0
14 15 1 0
15 16 1 0
16 17 2 0
17 12 1 0
17 18 1 0
18 19 1 0
19 20 2 0
19 21 2 0
19 22 1 0
22 23 2 0
1 2 1 0
23 27 1 0
2 3 1 0
3 5 1 0
26 24 1 0
4 1 2 0
24 25 2 0
25 22 1 0
4 5 1 0
5 6 1 0
26 27 1 0
6 7 1 0
27 28 2 0
7 8 1 0
28 29 1 0
8 4 1 0
29 30 2 0
3 9 2 0
30 31 1 0
31 26 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 508.70Molecular Weight (Monoisotopic): 507.9938AlogP: 3.23#Rotatable Bonds: 3Polar Surface Area: 82.83Molecular Species: NEUTRALHBA: 10HBD: 1#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: 9.65CX Basic pKa: 1.40CX LogP: 4.75CX LogD: 4.75Aromatic Rings: 3Heavy Atoms: 31QED Weighted: 0.43Np Likeness Score: -1.49
References 1. Saczewski J, Brzozowski Z, Saczewski F, Bednarski PJ, Liebeke M, Gdaniec M.. (2006) Synthesis and in vitro anti-tumor activity of N-{1-[(3-thioxo-5,6-dihydroimidazo[2,1-c][1,2,4]thiadiazol-7-ylthio)thiocarbonyl]-2-imidazolidene}arylsulfonamides., 16 (14): [PMID:16682194 ] [10.1016/j.bmcl.2006.04.067 ]